The reason why the SP is at .05 is because these clowns are actually serious about building a sustainable business.
In time .. you will see the transition ... EasyDNA was 1st up .. now Mutli-test ... NEXT we have Germline reimbursable Breast / Colorectal coming. I UNDERSTAND the history (different management) and hence can TRULY appreciate the frustration of HOLDERS (including me).
We now have CEO; CFO etc..........; and some medical advisors on board.
Lets not underestimate of THE accountability in getting approval for Multi-test is AUS / US (& Covid test in US) .. something must make sense for AUS/US authorities to approve ?
Yes - for succ a low Cap company ... Risk Vs REward is worth debating.
GLTAH ( and PLEASE DYOR)
GTG Price at posting:
0.5¢ Sentiment: Buy Disclosure: Held
